Greek pharmaceuticals reform may undermine industry
Undermining the output of high-value-added products will diminish the Greek economy's long-term overall competitiveness
You must be signed in to read this analysis
In this article
- Industry's economic footprint
- Resilience in time of crisis
- Further price cuts are foreseen
- Negative impact of third memorandum
- Repercussions throughout industry and worldwide
- Exports to markets with higher price levels
- Innovation is likely to be curtailed
What is this?
This article is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.